Docetaxel and exisulind in hormone-refractory prostate cancer

Christopher W. Ryan, Walter M. Stadler, Nicholas J. Vogelzang

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Docetaxel and exisulind in hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences